Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Restasis
Restasis
Restasis' first foray into Facebook drives big results for Allergan
Fierce Pharma
Mon, 04/10/17 - 10:03 am
Allergan
Restasis
dry eye disease
Facebook
social media
Biotechs line up to tap growing ophthalmics market
BioPharma Dive
Thu, 12/22/16 - 10:25 am
Ophthalmic Drugs Market
Ocular Therapeutix
Eylea
Restasis
Lucentis
Regeneron
Roche
Allergan
Allergan Is Losing Its No. 2 Product More Rapidly Than Expected
Seeking Alpha
Wed, 12/21/16 - 10:53 am
Allergan
dry eye disease
Restasis
Shire
Xiidra
Mylan scores review of Allergan's Restasis IP, but analysts aren't worried about the med's fate
Fierce Pharma
Sun, 12/11/16 - 11:44 am
Mylan Labs
Allergan
Restasis
patents
generics
Allergan's Restasis Faces Dry Eye Threat: Examining XIIDRA's Initial Sales Trends
Seeking Alpha
Tue, 11/8/16 - 10:09 am
Allergan
dry eye disease
Restasis
Xiidra
Shire
The Shire Vs. Allergan War Has Begun
Seeking Alpha
Mon, 08/1/16 - 09:39 am
Shire
Allergan
dry eye disease
Xiidra
Restasis
Shire targets Allergan's dry-eye market share by pricing Xiidra at $5K per year--right on par with Restasis
Fierce Pharma
Tue, 07/26/16 - 11:25 am
dry eye disease
Shire
Allergan
Xiidra
Restasis
Should Allergan Worry About Shire’s Win With Dry Eye Drug?
Bidness, ETC
Wed, 07/13/16 - 11:02 am
Allergan
Shire
dry eye disease
Restasis
Xiidra
Allergan execs see Restasis withstanding rivalry with prospective Shire med
Fierce Pharma Marketing
Wed, 02/24/16 - 10:50 am
Allergan
Shire
Restasis
Lifitegrast
dry eye disease
Shire's back on track with its dry-eye threat to Allergan's Restasis
Fierce Pharma Marketing
Wed, 01/27/16 - 10:25 am
Shire
dry eye disease
Allergan
Restasis
Lifitegrast
Auven Therapeutics pits rival PhIII dry eye drug against Allergan, Shire
Fierce Biotech
Fri, 11/13/15 - 11:01 am
Auven Therapeutics
dry eye disease
Seciera
Restasis
Allergan
Shire
Lifitegrast
Allergan Submits Prior Approval Supplement For Restasis
Bidness, ETC
Wed, 11/11/15 - 09:58 am
Allergan
Restasis
dry eye disease
Allergan Slips on Restasis Challenge
Yahoo/Zacks.com
Thu, 01/23/14 - 05:54 pm
Allergan
Restasis
dry eye disease
Actavis
generics
Allergan rides high on patent backing for key drugs Lumigan and Restasis
Fierce Pharma
Thu, 01/16/14 - 06:54 am
Allergan
patents
Lumigan
Restasis
Top 10 Drug Patent Losses of 2014
Fierce Pharma
Mon, 10/28/13 - 10:26 am
patents
Copaxone
Teva
Nexium
AstraZeneca
Micardis
Boehringer Ingelheim
Sandostatin LAR
Novartis
Exforge
Nasonex
Merck
TriLipix
AbbVie
Evista
Eli Lilly
Restasis
Allergan
Renagel
Sanofi
New FDA Guidelines Hit This Company Hard
Motley Fool
Fri, 08/30/13 - 08:47 am
FDA
Allergan
generics
Restasis
Allergan pushes FDA to defend Restasis from early generics
Fierce Pharma
Wed, 08/21/13 - 10:20 am
Allergan
Restasis
dry eye disease
FDA
generics
Allergan climbs after countering FDA draft on generic drug testing
The Fly on the Wall
Tue, 08/20/13 - 11:56 am
Allergan
FDA
generics
Restasis
For Allergan Shareholders, Will it Be Dry Eyes or Tears of Joy?
Motley Fool
Fri, 06/28/13 - 10:26 am
Allergan
Restasis
dry eye disease
FDA draft guidance on generic eye drug push Allergen shares lower
Reuters
Tue, 06/25/13 - 11:00 am
FDA
generics
Allergan
Restasis
Pages
« first
‹ previous
1
2
3